Skip to Main Content
TRC_PTL_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Hematology & Oncology
  4. Anemia

Anemia

  • Anemia (42)
    • Drug-Induced Anemia (11)
    • Drug Toxicity (13)
    • Prevention (4)
    • Related Conditions (18)
    • Treatment (18)
  • Blood Products (4)
  • Breast Cancer (65)
  • Cancer (17)
  • Cervical Cancer (14)
  • Chemotherapy (4)
  • Chemotherapy-Induced Adverse Effects (34)
  • Colon Cancer (14)
  • Drugs/Products That May Increase Cancer Risk (85)
  • Gastrointestinal Cancers (24)
  • Hemophilia (2)
  • Hemorrhage (6)
  • Leukemia (1)
  • Lung Cancer (77)
  • Lymphoma & Multiple Myeloma (1)
  • Ovarian Cancer (1)
  • Prostate Cancer (17)
  • Renal Cancer (1)
  • Resources (56)
  • Sickle Cell Disease (4)
  • Skin Cancer (20)
31 - 42 of 42 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: There's confusion about the different iron products August 2008
Guideline: National Kidney Foundation Guideline and Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target June 2007
Commentary: Safe Use of Erythropoiesis-Stimulating Agents (ESAs) June 2007
Commentary: Drug Therapy for Ulcerative Colitis March 2007
Guideline: Guidelines for the Management of Inflammatory Bowel Disease in Adults (2004) March 2007
Commentary: Drug Eluting Stents and Antiplatelet Medications February 2007
Guideline: ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention February 2007
Guideline: 2007 Science Advisory on Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients with Coronary Artery Stents February 2007
Guideline: 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention February 2007
Article: new FDA advisory on the erythropoietin analogues Procrit, Epogen, and Aranesp January 2007
Article: Aranesp (darbepoetin alfa), the new longer-acting erythropoietin analog for anemia November 2001
Other: New Drug: Aranesp (Darbepoetin Alfa) November 2001
  • « Prev
  • 1
  • 2
  • 3
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved